ArticleBiochemistry and biophysics reports2026
Dysregulated serum levels of human tissue kallikreins, hK7 and hK10, as potential biomarkers of asthma.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Asthma is a highly prevalent inflammatory disease worldwide with limited diagnostic and therapeutic approaches. Objective: This study was conducted to explore the possible role of hK7 and hK10 in asthma progression and evaluate them as potential biomarkers of asthma. Methods: In total, 74 patients with asthma and 99 normal controls participated in the study. Time-resolved immunofluorometric (TRIF) indirect back-titration (bt) ELISA was employed to measure the expression of hK7 and hK10 in both groups. Statistical analysis was performed using SPSS. Result: Results indicated hK7 upregulation and hK10 downregulation in patients with asthma as compared to normal controls. Further non-significant association of hK7 and hK10 expression with patients'age was noted. Conclusion: This study documents the true or impartial behavior of hK7 and hK10 being evaluated as biomarkers of asthma. The aberrant expression of these hKs can help to design diagnostic and therapeutic measures to control asthma. The associated factors need to be considered as they affect the expression of both KLK proteins. Further work is needed for the exploration and utilization of KLK proteins as drug targets fortherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.